HLAA Receives Permission from the FDA to Host a Meeting on Sensorineural Hearing Loss on May 25

HLAA has received permission from the U.S. Food and Drug Administration (FDA) to host an Externally-Led Patient-Focused Drug Development Meeting (EL-PFDD) for People and Families Living with Sensorineural Hearing Loss...HLAA has received permission from the U.S. Food and Drug Administration (FDA) to host an Externally-Led Patient-Focused Drug Development Meeting (EL-PFDD) for People and Families Living with Sensorineural Hearing Loss on Tuesday, May 25, from 10 a.m.-3 p.m., U.S. ET. This is a YouTube Live virtual meeting, and all are welcome to attend. You can … Read More >

HLAA Hosting a Webinar (April 8) and Convening a Meeting (May 25) with Permission from the FDA

HLAA will convene and host a Patient-Focused Drug Development (PFDD) meeting with permission from the Food and Drug Administration (FDA) on sensorineural hearing loss and its impact on daily life. All...HLAA will convene and host a Patient-Focused Drug Development (PFDD) meeting with permission from the Food and Drug Administration (FDA) on sensorineural hearing loss and its impact on daily life. All are welcome to attend. This session will be free and open to all. Look for more information to come. We will also hold an HLAA webinar on … Read More >